Correspondence 0001104659-23-062755 from AGILE THERAPEUTICS INC (AGRX, AGXRW) (CIK 0001261249)
AGILE THERAPEUTICS INC (AGRX, AGXRW) (CIK 0001261249)
Date: May 19, 2023 · CIK: 0001261249 · Accession: 0001104659-23-062755
AI Filing Summary & Sentiment
File numbers found in text: 333-271249
Show Raw Text
CORRESP
1
filename1.htm
May 19, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Washington, D.C. 20549
Re:
Agile Therapeutics, Inc.
Registration Statement on Form S-1 (File No. 333-271249)
Concurrence in Acceleration Request
Ladies and Gentlemen:
H.C. Wainwright &
Co., LLC (“Wainwright”), as placement agent for the referenced offering, hereby concurs in the request by Agile Therapeutics,
Inc. that the effective date of the above-referenced registration statement be accelerated to Monday, May 22, 2023, at 3:00
p.m. (Washington, D.C. time), or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms
that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.
Very truly yours,
H.C. WAINWRIGHT & CO., LLC
By:
/s/ Edward D. Silvera
Name: Edward D. Silvera
Title: Chief Operating Officer